3 recruiting. 1 Not applicable, 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Recruiting 1 |
| Phase 1 | 1 | Recruiting 1 |
| Phase 2 | 1 | Recruiting 1 |
Follow Resectable Glioblastoma: new trials by email Literature Review of Resectable Glioblastoma trials Research Report on Resectable Glioblastoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| GI-102 Alone or With Pembrolizumab Before Surgery for Treatment of Recurrent or Progressive IDH Wildtype Glioblastoma and IDH Mutated Grade 4 Astrocytoma Biospecimen Collection, Bispecific CD80-lgG4Fc-IL-2v Fusion Protein GI-102, Computed Tomography - Glioblastoma, IDH-Wildtype, Progressive Astrocytoma, IDH-Mutant, Grade 4 | Phase 2 | Recruiting | Mayo Clinic | 36 | 2026-08-03 | 2026-10-30 |
| ERAS-801 for the Treatment of Resectable and Progressive or Recurrent or Elderly Newly Diagnosed IDH Wildtype Grade IV Glioblastoma or Gliosarcoma With an EGFR Amplification or Mutation, ERAS801-SARG Trial Biospecimen Collection, Echocardiography Test, EGFR Inhibitor ERAS-801 - Glioblastoma, Glioblastoma, IDH-Wildtype | Phase 1 | Recruiting | Jonsson Comprehensive Cancer Center | 50 | 2025-07-28 | 2026-09-18 |
| Magnetic Resonance Imaging for Improving Knowledge of Brain Tumor Biology in Patients With Resectable Glioblastoma Biospecimen Collection, Magnetic Resonance Imaging, Medical Chart Review - Glioblastoma, Recurrent Glioblastoma | Not applicable | Recruiting | Jonsson Comprehensive Cancer Center | 50 | 2022-04-14 | 2025-11-10 |
Glioblastoma (3) · Gliosarcoma (2) · Astrocytoma (1)
Glioma (3) · Neoplasms (3) · Neoplasms by Histologic Type (3) · Neoplasms, Germ Cell and Embryonal (3) · Neoplasms, Glandular and Epithelial (3) · Neoplasms, Nerve Tissue (3) · Neoplasms, Neuroepithelial (3) · Neuroectodermal Tumors (3) · Astrocytoma (2)
Magnetic Resonance Spectroscopy (3) · Specimen Handling (3) · Surgical Procedures, Operative (2) · Fluorodeoxyglucose F18 (1) · pembrolizumab (1)
Jonsson Comprehensive Cancer Center (2) · Mayo Clinic (1)
United States (3)
Benjamin M Ellingson (1) · Jian L Campian, MD, PhD (1) · Phioanh Nghiemphu (1)
R01CA270027 (1), R01CA279984 (1)